Federal Supply Schedule 36F79719D0161
Award Date
6/1/19
Last Date to Order
1/31/25
Federal Agency
Veterans Integrated Service Network 12
Awardee
Marlex Pharmaceuticals Inc.
Ultimate Awardee
Not listed
NAICS Category
325412 - Pharmaceutical Preparation Manufacturing
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Pricing Type
Fixed Price with Economic Price Adjustment
Legislative Mandate
Not listed
National Interest Action
None
Award Type
Multiple
Primary Consortia Member
Not listed
Similar IDVs
The Department of Veterans Affairs (VA) awarded a $88 million Federal Supply Schedule (FSS) contract to Marlex Pharmaceuticals Inc., a minority-owned, self-certified small disadvantaged business located in New Castle, Delaware. The FSS contract, classified under FSS-61-IB Pharmaceuticals and Drugs, covers a period of 5 years through February 1, 2030. Under this FSS contract, Marlex Pharmaceuticals will supply a wide range of generic pharmaceutical products in tablet form to various federal...
The Federal Supply Schedule (FSS) contract award to Mylan Pharmaceuticals Inc. is for a five-year period, from January 1, 2023 to December 31, 2027, with a total ceiling value of $364,546,690.00. The contract was awarded by the Veterans Integrated Service Network 12 (VISN 12), a civilian agency under the Department of Veterans Affairs (VA), to provide a full range of drugs and hematology-related products. As the prime contractor, Mylan Pharmaceuticals will supply prescription medications and...
Marlex Pharmaceuticals Inc., a minority-owned small disadvantaged business, has been awarded a single-award Indefinite Delivery Contract by the U.S. Defense Logistics Agency Troop Support Medical, a defense agency, with a ceiling value of $9,215,304.68 and an ultimate completion date of July 9, 2030. Under this IDC, Marlex Pharmaceuticals is the prime contractor responsible for manufacturing and distributing a wide range of generic pharmaceutical products, including tablets of prednisone,...
This Federal Supply Schedule (FSS) contract, awarded by the Department of Veterans Affairs (VA) to Exela Pharma Sciences LLC, is for the procurement of pharmaceuticals, drugs, and hematology-related products under FSS-61-IB. The contract has a ceiling value of $3,030,000.00 and a period of performance through September 28, 2024. As a multiple-award schedule contract, this FSS allows the VA and other eligible federal agencies to issue task orders for a wide range of pharmaceutical and drug...
This indefinite delivery contract (IDC) was awarded by the National Acquisition Center, a civilian federal agency, to Marlex Pharmaceuticals Inc., a minority-owned, small disadvantaged business. The contract, valued at $14,155,681.05, is for the supply of ezetimibe tablets to the Department of Veterans Affairs (VA), Department of Defense (DoD), Bureau of Prisons, and Indian Health Service. The period of performance is one year with four one-year option periods, running from April 28, 2024 to...
This is a Federal Supply Schedule (FSS) contract awarded by the Department of Veterans Affairs (VA) to Apnar Pharma, LP, a minority-owned small disadvantaged business. The contract is for pharmaceutical and drug products under FSS Schedule 65 I B and has a total ceiling value of $2,225,000. The period of performance is from June 15, 2021 to June 14, 2026. The contract aims to procure a broad range of pharmaceutical and hematology-related products for the VA's Veterans Integrated Service...
This Federal Supply Schedule (FSS) contract was awarded by the Department of Veterans Affairs (VA) Veterans Health Administration to Mylan Specialty LP, a for-profit manufacturer of pharmaceuticals and medical devices. The contract, valued at up to $514,849,130, runs through January 2027 and allows the VA to issue task orders to procure pharmaceuticals, drugs, hematology products, and related medical supplies to serve the healthcare needs of veterans. Specifically, the contract covers National...
The contract is a Federal Supply Schedule (FSS) award to Mayne Pharma Commercial LLC, a foreign-owned, for-profit manufacturer of goods. The contract is for pharmaceutical and hematology-related products under FSS Schedule 65 I B, with a contract ceiling value of $53,029,735.90 and a period of performance from July 15, 2025 to July 14, 2030. The contracting agency is the Veterans Integrated Service Network 12, a civilian federal agency. The contract does not have any set-asides and was awarded...
The provided information details a Federal Supply Schedule (FSS) contract awarded by the U.S. Department of Veterans Affairs (VA) to Golden State Medical Supply, Inc., a for-profit pharmaceutical manufacturer and distributor based in Camarillo, California. The contract, identified as 65 I B, DRUGS, PHARMACEUTICALS, & HEMATOLOGY RELATED PRODUCTS, FSS CONTRACT AWARD, covers the delivery of a wide range of essential pharmaceutical products to federal healthcare facilities, including the VA,...
This federal supply schedule contract was awarded by the Department of Veterans Affairs (VA) to Melling LLC, doing business as Melling Medical, to provide pharmaceutical and medical products and services. The $31.28 million contract runs from March 2018 through March 2025 and is under the VA's Federal Supply Schedule 65-IB for Drugs, Pharmaceuticals, and Hematology Related Products. Melling Medical, a service-disabled veteran-owned small business, delivers a wide range of ophthalmic devices,...